Pediatric Psychopharmacology for Primary Care

Pay with

About Pediatric Psychopharmacology For Primary Care

Product Description Completely updated and revised, the second edition provides primary care physicians with practice-tested, condition-specific treatment recommendations for various childhood mental disorders. Obtain clear guidance on dosing, monitoring, and potential adverse reactions of psychotropic medications for treatment of common psychiatric disorders and mental health or behavioral problems in children and adolescents.   This simple, systematic approach defines discrete levels of psychotropics and spells out group-specific roles and responsibilities in accord with AAP policies. Plus, an included digital tool offers instant access to authoritative answers on specific conditions and medications. Includes bonus digital tool! Get instant answers on specific conditions and medications!   TOPICS INCLUDE Conceptual framework for prescribing psychotropic drugs Medications for specific diagnoses: ADHD, Anxiety, and Depression US Food and Drug Administration-Approved antipsychotics and mood stabilizers and all other medications What to do when treatment is unsuccessful Review "This is a useful reference for medications and therapies that help pediatric patients. The book provides important messages about assessment, prescribing, and when and how to refer." Sam Kohn, MD, FAAP Asheville Children's Medical Center, NC Journal of the American Academy of Child & Adolescent Psychiatry, Volume 57, Number 8, August 2018. 5-Star Review "This is an excellent resource and I am confident primary care clinicians will find it incredibly helpful in their practice. This edition contains updated guidelines and prescribing regulations and provides online access to additional resources and information."   Maria Alcocer Alkureishi, MD University of Chicago Pritzker School of Medicine Doody's Book ReviewTM   About the Author Mark A. Riddle, MD, is a Professor of Psychiatry and Pediatrics at the Johns Hopkins University School of Medicine.  His clinical work involves collaborating with primary care clinicians in a federally qualified health center and providing phone consultations to primary care clinicians. The focus of Dr Riddle’s research, teaching, and clinical practice is pediatric psychopharmacology, especially medication side effects.  His publications include over 300 research articles, reviews, chapters, and edited volumes.  He serves as a member of the NICHD-sponsored Data Monitoring Committee for the Best Pharmaceuticals for Children Act and as Chair of the Scientific Council of the NVLD Project. He was a member of the Institute of Medicine’s Committee on Review of Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act, and the principal investigator of an NIMH-sponsored, multisite study of interventions for children who have gained weight on antipsychotic medication, and the site-PI of a 6-year follow-up study of preschoolers who were treated with medication for ADHD.  He was the Director of the Division of Child and Adolescent Psychiatry at Johns Hopkins from 1993-2009 and was the founding chair of the Interventions Review Committee for Disorders Involving Children and Their Families at the National Institute of Mental Health.   Rebecca Baum, MD, FAAP is a developmental behavioral pediatrician at The Olson Huff Center at Mission Children’s Hospital in Asheville, NC.  She has led several clinical, educational, research, and quality improvement efforts at the state and national levels focused on improving care for children with behavioral health conditions.  She is a consultant to the American Board of Pediatrics Foundation’s Behavioral/Mental Health Crisis efforts and chair of the American Board of Pediatrics’ subboard of Developmental Behavioral Pediatrics.  She is a member of the American Academy of Pediatrics’ Committee on Psychosocial Aspects of Child and Family Health and liaison to the Section on Developmental Behavioral Pediatrics.